Verigene
Device
Luminex Corporation
Total Payments
$176,629
Transactions
11
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $176,629 | 11 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $175,039 | 7 | 99.1% |
| Honoraria | $1,590 | 4 | 0.9% |
Payments by Type
Research
$175,039
7 transactions
General
$1,590
4 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| ATL-EPF-01 Verigene II GI/GI-2 | Luminex Corporation | $129,385 | 0 |
| VER-BCY-01 VERIGENE II BC Yeast Assay | Luminex Corporation | $30,786 | 0 |
| ATL-RTI-01 Verigene II RSP/RSP Expanded | Luminex Corporation | $11,318 | 0 |
| ATL-CNS-01 VERIGENE II CNS Flex Panel | Luminex Corporation | $3,550 | 0 |
Top Doctors Receiving Payments for Verigene
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Freehold, NJ | $176,629 | 11 |
Ad
Manufacturing Companies
- Luminex Corporation $176,629
Product Information
- Type Device
- Total Payments $176,629
- Total Doctors 0
- Transactions 11
About Verigene
Verigene is a device associated with $176,629 in payments to 0 healthcare providers, recorded across 11 transactions in the CMS Open Payments database. The primary manufacturer is Luminex Corporation.
Payment data is available from 2024 to 2024. In 2024, $176,629 was paid across 11 transactions to 0 doctors.
The most common payment nature for Verigene is "Unspecified" ($175,039, 99.1% of total).
Verigene is associated with 4 research studies, including "ATL-EPF-01 Verigene II GI/GI-2" ($129,385).